EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research

Bernadette Mannaerts, Claus Yding Andersen, Colin M Howles

Reproductive BioMedicine Online · 2025-06 · 50 (6) · 104782

DOI: 10.1016/j.rbmo.2024.104782 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2025-06. Verfasst von Bernadette Mannaerts und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mannaerts Consultancy, Heesch, The Netherlands. Electronic address: b.mannaerts@trinedmail.nl. Hauptthemen laut MEDLINE: Chorionic Gonadotropin, Ovulation Induction, Luteinizing Hormone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review evaluates the effect of HCG and LH supplementation during ovarian stimulation. Controlled trials were divided into four groups comparing the treatment effect of recombinant FSH (r-FSH) with urinary FSH (u-FSH), with human menopausal gonadotrophin (HMG), with r-FSH + recombinant LH (r-LH) and with rFSH + recombinant HCG (r-HCG). First r-FSH seemed to be more potent than u-FSH in downregulated women, which translated into more follicles and oocytes. In line, numerous trials comparing HMG (containing u-FSH + u-HCG) with r-FSH demonstrated that HMG recruited fewer follicles, thus providing fewer oocytes but resulted in slightly higher pregnancy rates after a first fresh embryo transfer. The latter may be explained by the higher potency of r-FSH resulting in more and higher premature progesterone rises. Prospective trials addressing r-FSH + r-LH compared with r-FSH could not demonstrate any difference in pregnancy rates in normal or poor responders. A placebo-controlled trial of r-HCG added to a fixed daily r-FSH dose revealed that r-HCG inhibited the growth of intermediate follicles, resulting in fewer oocytes, fewer embryos and lower pregnancy rates. In conclusion, the beneficial effect of HCG and LH supplementation on clinical outcome has never been definitely proven for any of the combined gonadotrophin products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chorionic GonadotropinOvulation InductionLuteinizing HormoneHumansFemalePregnancyFollicle Stimulating HormonePregnancy RateTreatment Outcome

Stichwörter der Autor:innen

HCGHMGLHinhibition multi-follicular growth

Substanzen

Chorionic GonadotropinLuteinizing HormoneFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Mannaerts Consultancy, Heesch, The Netherlands. Electronic address: b.mannaerts@trinedmail.nl.
  • Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; The Fertility Clinic, Copenhagen University Hospital Herlev, Herlev, Denmark.
  • ARIES Consulting Sàrl, Geneva, Switzerland; Deanery of Biomedical Sciences, University of Edinburgh, UK.

Zitieren

APA

Mannaerts, B., Yding Andersen, C., & Howles, C. M. (2025). Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research. Reproductive BioMedicine Online, 50(6), 104782. https://doi.org/10.1016/j.rbmo.2024.104782

Vancouver

Mannaerts B, Yding Andersen C, Howles CM. Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research. Reproductive BioMedicine Online. 2025;50(6):104782. doi:10.1016/j.rbmo.2024.104782

BibTeX
@article{Mannaerts2025,
  author = {Mannaerts, Bernadette and Yding Andersen, Claus and Howles, Colin M},
  title = {Does HCG and LH supplementation during ovarian stimulation improve clinical outcome? An evaluation of 30 years of clinical research},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  volume = {50},
  number = {6},
  pages = {104782},
  doi = {10.1016/j.rbmo.2024.104782}
}
Kostenlos starten →